Proteasome inhibition sensitizes non–small cell lung cancer to histone deacetylase inhibitor–induced apoptosis through the generation of reactive oxygen species
- 28 September 2004
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 128 (5) , 740-748
- https://doi.org/10.1016/j.jtcvs.2004.07.010
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Combined proteasome and histone deacetylase inhibition in non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Modulation of antiapoptotic cell signaling pathways in non-small cell lung cancer: the role of NF-κBSeminars in Thoracic and Cardiovascular Surgery, 2004
- Ineffectiveness of Histone Deacetylase Inhibitors to Induce Apoptosis Involves the Transcriptional Activation of NF-κB through the Akt PathwayJournal of Biological Chemistry, 2003
- Inhibition of nuclear factor κB chemosensitizes non–small cell lung cancer through cytochrome c release and caspase activationThe Journal of Thoracic and Cardiovascular Surgery, 2002
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung CancerNew England Journal of Medicine, 2002
- Lung Cancer — Time to Move on from ChemotherapyNew England Journal of Medicine, 2002
- FLICE-Inhibitory Proteins: Regulators of Death Receptor-Mediated ApoptosisMolecular and Cellular Biology, 2001
- Histone deacetylases and cancer: causes and therapiesNature Reviews Cancer, 2001
- Inhibition of NF-κB sensitizes non–small cell lung cancer cells to chemotherapy-induced apoptosisThe Annals of Thoracic Surgery, 2000
- Mitochondrion as a Novel Target of Anticancer ChemotherapyJNCI Journal of the National Cancer Institute, 2000